Literature DB >> 9071739

Novel "scavestrogens" and their radical scavenging effects, iron-chelating, and total antioxidative activities: delta 8,9-dehydro derivatives of 17 alpha-estradiol and 17 beta-estradiol.

W Römer1, M Oettel, P Droescher, S Schwarz.   

Abstract

Antioxidant effects of delta 8,9-dehydro derivatives of 17 alpha-estradiol and 17 beta-estradiol were investigated using four different in vitro models: rat synaptosomal lipid peroxidation induced by Fenton's reagent, Fe(II)-chelating activities, the formation of superoxide anion radicals, and total antioxidative activities. The parent molecules, 17 alpha-estradiol and 17 beta-estradiol as well as estrone and estriol inhibit iron-dependent lipid peroxidation and stimulate total antioxidant activity. In contrast, delta 8,9-dehydro estrogens such as J811, J861, J835, or J851 not only exhibit the antioxidative activities as the parent molecules do but also directly alter the iron redox chemistry and drastically inhibit the formation of superoxide anion radicals generated by a xanthine/xanthine oxidase-dependent luminescence reactions. These in vitro findings indicate that 17 alpha-estradiol as well as 17 beta-estradiol, modified with an additional double bond in the basic structure, trigger more potent antioxidant properties. These results suggest that relatively minor modifications in the chemical structure of estrogenic compounds can enhance antioxidative actions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071739     DOI: 10.1016/s0039-128x(96)00224-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  8 in total

1.  Apoptotic morphology does not always require caspase activity in rat cerebellar granule neurons.

Authors:  E Daré; A M Gorman; E Ahlbom; M Götz; T Momoi; S Ceccatelli
Journal:  Neurotox Res       Date:  2001-10       Impact factor: 3.911

2.  Strategies for the protection of dopaminergic neurons against neurotoxicity.

Authors:  M Gerlach; K L Double; M B Youdim; P Riederer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  A facile total synthesis of ent-17beta-estradiol and structurally related analogues.

Authors:  Zu Yun Cai; Douglas F Covey
Journal:  Steroids       Date:  2006-12-27       Impact factor: 2.668

Review 5.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

Review 6.  The assessment of non-feminizing estrogens for use in neuroprotection.

Authors:  Kun Don Yi; Evelyn Perez; Shaohua Yang; Ran Liu; Douglas F Covey; James W Simpkins
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

7.  Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species.

Authors:  Baojian Xue; Yuanzi Zhao; Alan Kim Johnson; Meredith Hay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-03       Impact factor: 4.733

Review 8.  Nitric oxide and coronary vascular endothelium adaptations in hypertension.

Authors:  Andrew S Levy; Justin C S Chung; Jeffrey T Kroetsch; James W E Rush
Journal:  Vasc Health Risk Manag       Date:  2009-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.